STOKE THERAPEUTICS INC (STOK)

US86150R1077 - Common Stock

13.9  -0.13 (-0.93%)

After market: 13.9 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
7.85M8.78M12.41M0.000.00
Operating Expenses
126.30M123.55M116.76M86.07M53.04M
Research and Development
84.97M82.23M77.84M54.17M32.20M
Selling, General, and Administrative Expenses
41.33M41.32M38.92M31.90M20.85M
Operating Income
-118.45M-114.77M-104.36M-86.07M-53.04M
Interest Income/Expense
10.23M9.91M3.12M120.00K740.00K
Other Income/Expense
-307.00K166.00K170.00K140.00K60.00K
Income Before Taxes
-108.52M-104.70M-101.07M-85.81M-52.24M
Net Income
-108.52M-104.70M-101.07M-85.81M-52.24M
EBITDA
-116.02M-112.30M-102.81M-85.10M-52.15M
 
Per Share Data
EPS Diluted Total Ops
-2.41-2.38-2.60-2.34-1.56
Non GAAP EPS
-2.41-2.37-2.60-2.33-1.56
 
Statistics
Profit Margin
-1382.80%-1192.47%-814.42%N/AN/A
Operating Profit Margin
-1509.28%-1307.21%-840.93%N/AN/A

All data in USD

Charts